The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The New Zealand medical journal

• Publication date

  2004-10-08

• Fields of study

  Medicine

• Identifiers
  PMID 15477929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Therapeutic roles of coenzyme Q10 in peripheral nerve injury-induced neurosensory disturbances: Mechanistic insights from injury to recovery.

  2024cites this paper
• Coenzyme Q10: Does it benefit neurological diseases?

  2024cites this paper
• Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.

  2022cites this paper
• The Use of the Coenzyme Q10 as a Food Supplement in the Management of Fibromyalgia: A Critical Review

  2022cites this paper
• Impact of coenzyme Q10 on inflammatory biomarkers and its role in future therapeutic strategies.

  2021cites this paper
• Coenzyme Q10: Clinical Applications in Cardiovascular Diseases

  2020cites this paper
• Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.

  2019cites this paper
• Coenzyme Q10

  2019cites this paper
• Coenzyme Q10 Supplementation in Aging and Disease

  2018cites this paper
• The Whole Truth about Coenzyme Q10 You May Not Find Elsewhere

  2018cites this paper
• An Evidence-Based Review of Dietary Supplements on Inflammatory Biomarkers in Obesity

  2018cites this paper
• Regulation of complementary medicines

  2017cites this paper
• Different Q 10-Formulations Result in an Increase in the Fast Beta-Domain of the EEG

  2017cites this paper
• Changes within the Electroencephalogram and Increase in Mental Concentration are related to Differences in Solubulisation and Composition of Different Q10-Formulations

  2016cites this paper
• Coenzyme Q10 for the treatment of heart failure: a review of the literature

  2015cites this paper
• Quantification of the Reduced Form of Coenzyme Q10, Ubiquinol, in Dietary Supplements with HPLC-ESI-MS/MS

  2014cites this paper
• Coenzyme Q10 oral bioavailability: effect of formulation type

  2013influential citation
• Pharmacokinetic Comparison of a Generic Coenzyme Q10 Solubilizate and a Formulation with Soybean Phytosterols

  2012influential citation
• A Randomized, Double-Blind, Placebo-Controlled Crossover Study of Coenzyme Q 10 Therapy in Hypertensive Patients With the Metabolic Syndrome

  2012cites this paper
• A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.

  2012cites this paper
• The quality of commercially available nutraceutical supplements and food sources

  2011influential citation
• Coenzyme Q10: Clinical Update and Bioavailability

  2011cites this paper
• Emulsification of coenzyme Q10 using gum arabic increases bioavailability in rats and human and improves food-processing suitability.

  2010cites this paper
• Coenzyme Q10 Supplementation for the Treatment of Statin Induced Myalgia

  2010influential citation
• Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations

  2010influential citation
• Microencapsulation of ubiquinone-10 in carbohydrate matrices for improved stability.

  2010cites this paper
• Balancing Randomized Trials With Anecdote

  2009cites this paper
• A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.

  2009cites this paper
• Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.

  2009cites this paper
• Pharmacokinetic Profiles of Coenzyme Q10: Absorption of Three Different Oral Formulations in Rats

  2009cites this paper
• Regulation of complementary medicines

  2009cites this paper
• Coenzyme Q10: is there a clinical role and a case for measurement?

  2008cites this paper
• Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials

  2007cites this paper
• Concentration response to the coenzyme Q10 supplement Q-Gel in human volunteers.

  2007cites this paper
• Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.

  2007cites this paper
• Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

  2007cites this paper
• The uptake and distribution of coenzyme Q10.

  2007cites this paper
• The uptake and distribution of coenzyme Q(10)

  2007cites this paper
• Coenzyme Q10 in cardiovascular disease.

  2007cites this paper
• Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu™ Q10)

  2006cites this paper
• Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.

  2006cites this paper
• Clinical perspectives of statin-induced rhabdomyolysis.

  2006cites this paper
• Emerging chemotherapeutic strategies for Huntington’s disease

  2005cites this paper